Aytu BioPharma, Inc. (0A8M.L)
| Previous close | 2.7400 |
| Open | 0.0000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0000 - 0.0000 |
| 52-week range | |
| Volume | |
| Avg. volume | 623 |
| Market cap | N/A |
| Beta (5Y monthly) | -1.26 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
GlobeNewswirePresenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now
MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 69th Emerging Growth Conference on April 3 & 4, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting compani
Insider MonkeyAytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript
Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call Transcript February 14, 2024 Aytu BioPharma, Inc. beats earnings expectations. Reported EPS is $-0.04, expectations were $-0.25. Aytu BioPharma, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the […]
Simply Wall St.Aytu BioPharma Second Quarter 2024 Earnings: Beats Expectations
Aytu BioPharma ( NASDAQ:AYTU ) Second Quarter 2024 Results Key Financial Results Revenue: US$22.9m (down 13% from 2Q...
